Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Released Mar 29, 2022, after the close
10-K filed Mar 29, 2022, 88 days after period end · 0001654954-22-004036
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$10.81M | -$2.83M | -$14.00M | -$18.74M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 29, 2022 · 88 d after period end
